|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/5383 | (2006.01) |
| A61K 33/06 | (2006.01) | ||
| A61K 9/12 | (2006.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 2473170 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10814595.4 |
| Date of filing the European patent application | 2010-09-03 | |
| (97) | Date of publication of the European application | 2012-07-11 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
| (46) | Date of publication of the claims translation | 2019-10-10 |
| (86) | Number | PCT/US2010/047903 |
| Date | 2010-09-03 |
| (87) | Number | WO 2011/029059 |
| Date | 2011-03-10 |
| (30) | Number | Date | Country code |
| 249231 P | 2009-10-06 | US | |
| 240092 P | 2009-09-04 | US |
| (72) |
LOUTIT, Jefferey, S., US
MORGAN, Elizabeth, E., US
DUDLEY, Michael, N., US
GRIFFITH, David, C., US
LOMOVSKAYA, Olga, US
|
| (73) |
Horizon Therapeutics U. S. Holding LLC,
1 Horizon Way, Deerfield, Illinois, 60015,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Aerozolizuoto levofloksacino panaudojimas cistinės fibrozės gydymui |
| USE OF AEROSOLIZED LEVOFLOXACIN FOR TREATING CYSTIC FIBROSIS |
| Payment date | Validity (years) | Amount | |
| 2025-08-20 | 16 | 347.00 EUR |
| 2026-09-03 |